Skip to main content
Log in

A case of limited cutaneous systemic sclerosis developing anti-mitochondria antibody positive primary biliary cirrhosis after acute myocardial infarction

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In this report, we present a 63-year-old woman who had limited cutaneous systemic sclerosis and subsequently developed typical primary biliary cirrhosis after an acute myocardial infarction. The patient initially developed Raynaud’s phenomenon, and 4 years later visited the clinic in 1994 complaining of abdominal distress, xerostomia, and xerophthalmia. A diagnosis of limited cutaneous systemic sclerosis was based on Raynaud’s phenomenon, sclerodactyly and anti-centromere antibodies. She was also found to have anti-inositol 1,4,5-trisphosphate receptor 3 (IP3R3) antibodies, but anti-mitochondrial antibodies were only weakly positive. Seven years later, she developed vertigo and nausea, and was hospitalized due to complaints of an oppressive sensation of the anterior chest. Electrocardiogram results showed a reduction of R waves and ST segment elevation in II, III, and aVf leads. Coronary angiography showed 99% obstruction of the left anterior descending artery and 50% of stenosis of the right coronary artery. Three years later, the patient was noted to have anti-mitochondrial antibodies. Retrospective analysis of the patient’s sera showed that IP3R3 antibodies were decreasing. Since myocardium is particularly rich in mitochondria, it is thought that myocardial infarction may have been the triggering event that initiated antigen-presenting cells to selectively induce an anti-mitochondrial antibody response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77:1627–1631

    Article  PubMed  CAS  Google Scholar 

  2. Makinen D, Fritzler MJ, Davis P, Sherlock S (1983) Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 26:914–917

    Article  PubMed  CAS  Google Scholar 

  3. Fritzler MJ, Manns MP (2002) Anti-mitochondrial antibodies. Clin Appl Immunol Rev 3:87–113

    Article  CAS  Google Scholar 

  4. Iwai M, Tateishi Y, Hattori M, Mizutani A, Nakamura T, Futatsugi A et al (2005) Molecular cloning of mouse type 2 and type 3 inositol trisphospate receptors and identification of a novel type 2 receptor splice variant. J Biol Chem 18(280):10305–10317

    Article  Google Scholar 

  5. Pillmer SR, Casiola-Rosen L, Baum BJ, Gelber AC (2004) Centromere protein C is a target of autoantibodies in Sjogren’s syndrome is uniformly associated with antibodies to Ro and La. J Rheumatol 31:1121–1125

    Google Scholar 

  6. Butler P, Hamilton-Miller J, Baum H, Burroughs AK (1995) Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogens of primary biliary cirrhosis? Biochem Mol Biol Int 35:473–485

    PubMed  CAS  Google Scholar 

  7. Hirakata M, Akizuki M, Miyachi K, Matsushima H, Okano T, Homma M (1988) Coexistence of CRERST syndrome and primary biliary cirrhosis. J Rheumatol 15:1166–1170

    PubMed  CAS  Google Scholar 

  8. Okano T, Hirakata M, Mimori T, Akizuki M (1989) Frequency of anti-centromere antibodies in the mitochondrial antibody positive sera. Rinsho Byori 37:1267–1272

    Google Scholar 

  9. Parveen S, Morshed SA, Nishioka M (1995) High prevalence of antibodies to recombinant CENP B in PBC: nuclear immunofluorescence pattern and ELISA reaction. J Gastroenterol Hepatol 10:438–445

    PubMed  CAS  Google Scholar 

  10. Whyte J, Hough D, Maddison PJ, McHugh NJ (1994) The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigen. J Autoimmun 71:413–424

    Article  Google Scholar 

  11. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K et al (2005) IP3Receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309:2232–2234

    Article  PubMed  CAS  Google Scholar 

  12. Wang H, Bloom O, Zhang M et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyomitsu Miyachi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyachi, K., Hankins, R., Ihara, M. et al. A case of limited cutaneous systemic sclerosis developing anti-mitochondria antibody positive primary biliary cirrhosis after acute myocardial infarction. Clin Rheumatol 26, 1571–1574 (2007). https://doi.org/10.1007/s10067-006-0465-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0465-1

Keywords

Navigation